findmyKOL

Peter Alpert, MD

Basic profile

Albert Einstein College of Medicine

ORCIDNone on fileNPI
RegionBronx, NY · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Peter Alpert is an Infectious Disease physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 10 publications with 452 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

452citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Mmc - Dept. Of Medicine
3400 Bainbridge Avenue, 2nd Fl
Bronx, NY 10467

Telephone

718-920-7364

Registry record last updated 13 Dec 2011.

View the NPPES registry record

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    31.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.9%
    Dovato53%Tivicay24%Juluca11%Isentress8%Cabenuva4%
    Part D<11 patients
    Protease Inhibitor5.9%
    Prezcobix29%Symtuza26%Ritonavir22%Darunavir17%Evotaz4%Prezista3%
    Part D<11 patients

    + 9 more classes in this area

  • Cardiovascular

    25.8%
    Statin9.6%
    Atorvastatin Calcium63%Rosuvastatin Calcium23%Pravastatin Sodium9%Simvastatin6%
    Part D<11 patients
    Calcium channel blocker5.6%
    Amlodipine Besylate71%Nifedipine Er30%
    Part D46 patients

    + 13 more classes in this area

  • Nervous system

    16.9%
    gamma-Aminobutyric Acid A Receptor Positive Modulator4.4%
    Zolpidem Tartrate97%Zolpidem Tartrate Er4%
    Part D<11 patients
    Opioid Agonist2.5%
    Oxycodone-Acetaminophen38%Tramadol Hcl31%Oxycodone Hcl15%Morphine Sulfate Er11%Endocet6%
    Part D<11 patients

    + 16 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”